Duplicated zebrafish insulin‐like growth factor binding protein‐5 genes with split functional domains: evidence for evolutionarily conserved IGF binding, nuclear localization, and transactivation activity by Dai, Wei et al.
The FASEB Journal • Research Communication
Duplicated zebrafish insulin-like growth factor binding
protein-5 genes with split functional domains:
evidence for evolutionarily conserved IGF binding,
nuclear localization, and transactivation activity
Wei Dai, Hiroyasu Kamei, Yang Zhao, Jun Ding, Zhou Du, and Cunming Duan1
Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor,
Michigan, USA
ABSTRACT Insulin-like growth factor binding pro-
tein (IGFBP)-5 is a secreted protein that binds to IGF
and modulates IGF actions. IGFBP-5 is also found in
the nucleus of mammalian cells and has transactivation
activity. The structural basis of this transactivation
activity and its role in mediating IGF-independent
actions are not clear. Here we report that there are 2
igfbp-5 genes in zebrafish and other teleost fish. In
zebrafish, igfbp-5a and -5b are expressed in spatially
restricted, mostly nonoverlapping domains during early
development. The IGF binding site is conserved in both
zebrafish IGFBP-5s, and they are both secreted and
capable of IGF binding. Both proteins contain a con-
sensus bipartite nuclear localization signal and were
found in the nucleus when introduced into cultured
cells. Although zebrafish IGFBP-5b possesses transacti-
vation activity, zebrafish IGFBP-5a lacks this activity.
Mutational analysis demonstrated that 2 unique amino
acids in positions 22 and 56 of IGFBP-5a are responsible
for its lack of transactivation activity. These findings
suggest that the duplicated zebrafish IGFBP-5s have
evolved divergent regulatory mechanisms and distinct
biological properties by partitioning of ancestral struc-
tural domains and provide new evidence for a conserved
role of the IGF binding, nuclear localization, and transac-
tivation domain of this multifunctional IGFBP.—Dai, W.,
Kamei, H., Zhao, Y., Ding, J., Du, Z., Duan, C. Duplicated
zebrafish insulin-like growth factor binding protein-5
genes with split functional domains: evidence for evolu-
tionarily conserved IGF binding, nuclear localization, and
transactivation activity. FASEB J. 24, 2020–2029 (2010).
www.fasebj.org
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Regulation of peptide growth factor actions by se-
creted binding proteins has emerged as a common
mechanism in cellular signaling. Among the most ex-
tensively studied examples are the insulin-like growth
factor binding proteins (IGFBPs). Six distinct IGFBPs,
designated as IGFBP-1 to -6, have been characterized in
humans and other mammals (1, 2). These IGFBPs bind
to IGFs with equal or even greater affinities than do the
IGF-1 receptors (IGF-1Rs) and modulate the distribu-
tion, stability, and biological activities of IGFs.
IGFBP-5 is the most conserved member of the IGFBP
family. Mammalian IGFBP-5 has a highly conserved N
domain where the primary ligand binding domain (LBD)
is located (3) and a conserved C domain containing a
nuclear localization signal (NLS) (1, 4). The central variable
linker (L) domain contains several post-translational modi-
fication sites. Studies have suggested that IGFBP-5 is a
multifunctional protein. In the blood, IGFBP-5 can form a
ternary complex with IGF and the acid labile subunit
(ALS). This ternary complex controls the efflux of IGFs
from the vascular space and prolongs the half-lives of IGFs
(1). In cultured cells, IGFBP-5 has been shown to inhibit
IGF activities by binding to IGF and inhibiting IGF
binding to the cell surface IGF-1 receptor (IGF-1R) (5).
IGFBP-5 has also been shown to potentiate IGF actions via
its interactions with extracellular matrix (ECM) compo-
nents (6–8). Recent studies suggest that IGFBP-5 itself
can act as a growth factor with cellular effects that are not
dependent on its IGF-binding ability (9–12). In addition
to these findings based on studies in various mammalian
cell culture systems, recent mouse genetic studies have
begun to shed light on the IGF-dependent and -indepen-
dent actions in vivo (13–15).
Despite this progress, the molecular and biochemical
mechanisms underlying the IGF-independent actions
of IGFBP-5 are still poorly understood. Recent studies
suggest that mammalian IGFBP-5 is not only secreted
but also can be found in the nucleus and has the ability
to interact with nuclear proteins (4, 16–20). Further-
more, the IGFBP-5 N domain has been shown to have a
functional transactivation (TA) domain that is separa-
ble from its IGF binding site (19, 21). The in vivo roles
of the nuclear IGFBP-5 and its TA domain in mediating
the IGF-independent actions, however, are not clear.
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Addressing this issue using the mouse model is difficult
because of the redundancy issues inherited with the
mammalian systems and because of the multiple func-
tionality nature of IGFBP-5.
Like in mammals, the IGF signaling systems in te-
leosts are composed of IGF ligands, receptors, and
IGFBPs (22). Recent studies have suggested that many
teleost fish, including zebrafish, experienced an addi-
tional genome wide duplication event (23, 24). For
instance, there are 2 functional genes for IGF-1R,
IGFBP-1, IGFBP-2, and IGFBP-6 in zebrafish (25–29).
In this study we present evidence that zebrafish and
several other fishes possess 2 functional igfbp-5 genes.
Exploiting the availability of 2 zebrafish IGFBP-5s, we
show that the duplicated zebrafish IGFBP-5s have
evolved distinct biological properties by partitioning of
ancestral structural domains, such as the TA domain.
MATERIALS AND METHODS
All chemicals and reagents were purchased from Fisher
Scientific (Pittsburgh, PA, USA) unless stated otherwise.
Restriction enzymes were purchased from Promega (Madi-
son, WI, USA). TaqDNA polymerase and Vent DNA polymer-
ase were purchased from New England Biolabs (Ipswich, MA,
USA). Oligonucleotide primers and cell culture media were
purchased from Invitrogen (Carlsbad, CA, USA).
Animals
Wild-type zebrafish (Danio rerio) were maintained on a 14/10
h light-dark cycle at 28°C and fed twice daily. Fertilized eggs
were raised in embryo medium at 28.5°C and staged accord-
ing to the standard method (30). To inhibit pigmentation,
embryo medium was supplemented with 0.003% (w/v) N-
phenylthiourea. All experiments were carried out in accor-
dance with the guidelines established by the University Com-
mittee on the Use and Care of Animals at the University of
Michigan (http://www.ucuca.umich.edu).
Molecular cloning and molecular evolutionary analyses
Two zebrafish cDNAs encoding IGFBP-5-like sequences were
found by database search and by screening a cDNA library.
Their full-length cDNA sequences were determined by 5 and 3
rapid amplification of cDNA ends (RACE) using the SMART
RACE kit (Clontech, Mountain View, CA, USA). Amino acid
sequences of IGFBP-5s were aligned by ClustalX (31). Phyloge-
netic analyses were conducted using full-length amino acid
sequences by the minimum evolution method in MEGA4 (32).
The GenBank accession numbers of various IGFBPs are listed in
Supplemental Table 1. The structures of the 2 zebrafish igfbp-5
genes were determined by comparing full-length cDNAs and the
zebrafish genome sequence (http://www.genome.ucsc.edu/
cgi-bin/hgBlat). Synteny analysis was carried out based onHomo
sapiens Build 36.3, Mus musculus Build 37.1, Danio rerio Zv7,
Takifugu rubripes FUGU 4.0, and Gasterosteus aculeatus BROAD
S1. Genes used for this study are summarized in Supplemental
Table 2.
Reverse transcription (RT)-PCR and whole-mount in situ
hybridization
Total RNA was isolated from embryos and adult zebrafish tissues
using TRIzol reagent (Invitrogen). Onemicrogram of total RNA
was reverse transcribed to single-strand cDNA using M-MLV
reverse transcriptase (Invitrogen) according to the manufacturer’s
instructions. RT-PCR was performed with 3 sets of primers
(igfbp-5a: 5-GGGTACATGTGGACGAGGA-3 and 5-
GAAAGAGCCATCACTCTGGAA-3; igfbp-5b: 5-GGGAGTGTG-
TACGAACGAGAA-3 and 5-TCCTGTCACAGTTAGGCAG-
GTA-3; -actin: 5-GCCGGTTTTGCTGGAGATGAT-3 and 5-
ATGGCAGGGGTGTTGAAGGTC-3) using TaqDNA
polymerase.
For whole-mount in situ hybridization analysis, plasmids con-
taining complete CDS (igfbp-5a: 807 bp; igfbp-5b: 798 bp) or
partial 3 UTRs (igfbp-5a: 501 bp; igfbp-5b: 485 bp after stop
codon) were linearized by restriction enzyme digestion, followed
by in vitro transcription reactions with either T7 or SP6 RNA
polymerase (Promega), to generate antisense or sense ribo-
probes using DIG RNA labeling mix (Roche, Indianapolis, IN,
USA). The specificity of the riboprobes was verified by dot-blot
assay, and they did not cross-react with each other’s target.
Hybridization was carried out as described previously (25).
Construction of plasmids
To produce purified recombinant proteins for biochemical
assays, the open reading frames (ORFs) (with the stop codon
deleted) of zebrafish IGFBP-5a and IGFBP-5b and human
IGFBP-5 were amplified by PCR and subcloned into
pcDNA3.1()/myc-His A expression vector (Invitrogen) at XhoI
and HindIII sites. To determine the subcellular localization of
the 2 zebrafish IGFBP-5s, their ORFs (with the stop codon
deleted) were amplified by PCR and subcloned into pCS2/
enhanced green fluorescent protein (EGFP) expression vector
as reported previously (33). The construction of human IGFBP-
4:EGFP and IGFBP-5:EGFP constructs was already reported
(19). To produce the GAL4 DNA-binding domain (DBD) and
IGFBP-5a N-domain fusion protein, a DNA fragment corre-
sponding to the N domain of zebrafish IGFBP-5a was generated
by PCR and subcloned into pBIND vector (Promega). The
pBIND constructs containing human IGFBP-5 or zebrafish
IGFBP-5b N domain were already reported (19, 21). The
IGFBP-5 N-domain mutants were generated by PCR using Pfu
Turbo DNA polymerase (Stratagene, La Jolla, CA, USA) as
described previously (21). Primers used for constructing
these plasmids are listed in Supplemental Table 3. All con-
structs were sequenced at the University of Michigan DNA
Sequencing Core Facility.
Expression and purification of recombinant proteins
Myc- and 6xHistidine-tagged human and zebrafish IGFBPs were
produced and purified following previously reported proce-
dures (27). The purified proteins were quantified using a BCA
protein assay kit (Pierce Biotechnology, Rockford, IL, USA).
The purity was confirmed by silver staining and Western immu-
noblot using an anti-c-myc (9E10) antibody (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA). Their IGF binding abilities were
determined by ligand blot using digoxigenin-labeled human
IGF-1 following published procedure (34).
Cell-growth assay
The biological activities of various IGFBP-5s were studied using
the MTS assay (Promega) in cultured human embryonic kidney
(HEK) 293 cells and human osteosarcoma (U2OS) cells. Cells
were cultured in DMEM (HEK 293) or McCoy’s 5A (U2OS)
supplemented with 10% FBS, penicillin, and streptomycin in a
humidified-air atmosphere incubator containing 5% CO2. After
20 h serum starvation, 25 nM purified IGFBP was added in the
presence or absence of 25 nM IGF-1 (Novozymes GroPep,
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Adelaide, SA, Australia). The assays were terminated after 48 h,
following the manufacturer’s instructions.
Subcellular localization of zebrafish IGFBP-5a and -5b
U2OS cells were transiently transfected with an IGFBP:EGFP
expression vector using Lipofectamine 2000 (Invitrogen),
following the manufacturer’s instructions. Twenty-four hours
after transfection, cells were washed with 1 PBS, fixed by 4%
paraformaldehyde for 1 h, and stained with 0.5 g/ml
4,6-diamidino-2-phenylindole (DAPI) for 5 min. The cells
were washed, mounted, and examined under a fluorescence
microscope (Nikon Eclipse E600; Nikon, Tokyo, Japan).
Images were acquired using Leica TCS SP5 confocal micro-
scope with the Leica LAS AF software (Leica Microsystems,
Wetzlar, Germany).
Transcription activation assay
Mammalian one-hybrid transcription activation assay was per-
formed as described previously (21). The TA activities of
various IGFBPs were also examined in a zebrafish embryonic
cell line (ZF4). ZF4 cells were cultured in DMEM/F12
supplemented with 10% FBS, penicillin, and streptomycin in
a humidified-air atmosphere incubator containing 5% CO2 at
28°C. FuGENE 6 (Roche) was used for transfection in ZF4
cells. Twenty-four hours after transfection, cells were washed
and lysed. TA activity was quantified using the Dual-Lucif-
erase Reporter Assay System (Promega). To detect the expres-
sion level of GAL4 (DBD):IGFBP N-domain fusion proteins,
equal amounts of cell lysates were separated by 12.5% SDS-
PAGE and transferred to Immobilon P membranes (Milli-
pore, Billerica, MA, USA), followed by Western immunoblot
using an anti-GAL4 (DBD) (RK5C1) antibody (Santa Cruz
Biotechnology) and an anti-tubulin antibody (Sigma-Aldrich,
St. Louis, MO, USA).
Statistics
All values are represented as means  sd. Statistical differ-
ences among experimental groups were analyzed by 1-way
analysis of variance (ANOVA), followed by the Newman-Keuls
multiple comparison test using GraphPad Prism 5 (GraphPad
Software, La Jolla, CA, USA).
RESULTS
Identification of 2 igfbp-5 genes in zebrafish and other
teleost fish species
By searching public databases, screening a cDNA library,
and performing 5- and 3-RACE experiments, we identi-
fied and cloned 2 distinct zebrafish genes (GenBank
accession numbers GQ892882 and AY100478). For rea-
sons evident thereafter, we termed them as igfbp-5a and -5b
and the encoded proteins as IGFBP-5a and -5b. As shown
in Fig. 1A, zebrafish IGFBP-5a has a putative signal pep-
tide of 19 amino acids (aa) and a mature protein of 249
aa. IGFBP-5b has a putative signal peptide of 17 aa and a
mature protein of 248 aa. Comparison of the 2 zebrafish
IGFBP-5 sequences with 6 human IGFBPs revealed that
they share the highest sequence identities with that of
human IGFBP-5 (47–52%; see Supplemental Table 4).
Their sequence identities to human IGFBP-3 are 36 and
37%, and below 30% to other human IGFBPs. There is a
typical IGFBP motif in the N domain and a thyroglobulin
type-1 repeat in the C domain in both zebrafish IGFBP-5s.
Both proteins contain a consensus LBDmotif (3) in the N
domain and an NLS motif (4) in the C domain (Fig. 1A).
Phylogenetic analysis grouped both proteins into the
IGFBP-5 subgroup (Fig. 1B). The 2 zebrafish igfbp-5
genes also share similar exon/intron organization with
the human IGFBP-5 gene: they all contain 4 exons and
3 introns (Fig. 1C). Although zebrafish igfbp-5a is lo-
cated on LG6, igfbp-5b is on LG9. The 2 zebrafish igfbp-5
genes are adjacent to the 2 previously reported igfbp-2
genes (28), arranged in a tail-to-tail fashion (Fig. 1D).
This is very similar to the situations in the human and
mouse genomes (35).
To determine whether there are 2 igfbp-5 genes in
other teleost fish, we searched the fugu, stickleback,
medaka, and tetraodon genome databases and found
that they all contain 2 igfbp-5 genes. Again, the 2 igfbp-5
genes are adjacent to 2 igfbp-2 genes in a tail-to-tail
fashion in all these teleost genomes (Fig. 1D). Likewise,
there are several other syntenic genes (TNS1, STK11IP,
SLC4A3) (Fig. 1D). Phylogenetic analysis indicated that
the duplication of the igfbp-5a/b subfamily likely origi-
nated from a genome duplication event that occurred
early during ray-fin fish evolution (Fig. 1E).
The duplicated igfbp-5 genes exhibit distinct
expression patterns
As shown in Fig. 2A, in adult tissues, igfbp-5a mRNA was
detected in brain and gill at high levels. It was also
detected in eye, heart, gut, kidney, and gonad, but not in
liver and muscle by RT-PCR (Fig. 2A). In comparison,
igfbp-5bmRNAwas expressed in all adult tissues examined.
There were no obvious gender differences (Fig. 2A).
During early development, igfbp-5amRNA was not detect-
able until 14 h postfertilization (hpf). It gradually in-
creased from 14 to 72 hpf and was maintained at high
levels thereafter (Fig. 2B). In 8-hpf embryos, igfbp-5b
mRNA was detected at low levels. Starting from 12 hpf,
igfbp-5b mRNA levels maintained at high levels thereafter
(Fig. 2B). The results of whole-mount in situ hybridization
analysis are shown in Fig. 2C, D. We first detected igfbp-5a
mRNA at 20 hpf in a small number of cells on the surface
of the yolk sac and yolk tube, and this became more
evident at 36 hpf (Fig. 2Ca). The number of igfbp-5a
mRNA-expressing cells increased as the embryos grew
(Fig. 2Cb). At 96 and 120 hpf, igfbp-5a mRNA was also
highly expressed in cells spreading in the gill filament
regions (Fig. 2Cc). We also detected igfbp-5a mRNA in a
small number of cells located within the inner ear (Fig.
2Cd–f). In contrast, igfbp-5b mRNA was primarily detected
in differentiating somites, gill arches, pectoral fin, and
some neural tissues (Fig. 2D). Its expression in the somites
disappeared at 60 hpf (Fig. 2Db). At 36 and 48 hpf, igfbp-5b
mRNA was also highly expressed in the epithelial cells in
the otic vesicles (Fig. 2Dc, d). In larvae (120 hpf), igfbp-5b
mRNA was detected in the layers of cells surrounding the
gill cartilage (Fig. 2De) and some cells in the brain (Fig.
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Figure 1. There are 2 igfbp-5 genes in zebrafish and other teleost fish. A) Sequence alignment of human IGFBP-5 and zebrafish
IGFBP-5a and -5b. Identical and similar amino acid residues are darkly and lightly shaded, respectively. Vertical lines indicate the
boundaries between signal peptide, N, L, and C domains. Residues in the N domain known to be critical for IGF binding (LBD) are
underlined. NLS is shown in box. Asterisks indicate residues that are critical for the TA activity of human IGFBP-5. B) Phylogenetic
tree of the IGFBP family. Values on branches are percentages of replicate trees in which the genes clustered together in the bootstrap
test (1000 replicates). Branch lengths are drawn in units of 0.1 aa substitutions/site. C) Structure of human IGFBP-5 and zebrafish
igfbp-5a and -5b. Exons are shown as boxes and introns as lines. Lightly and darkly shaded areas represent (continued on next page)
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2Df). These results suggest that the 2 igfb-5 genes are ex-
pressed in nonoverlapping domains during development.
Both IGFBP-5a and -5b are secreted proteins, and
they both bind to IGF and modulate IGF actions
To test whether zebrafish igfbp-5a and -5b encode func-
tional IGFBPs, recombinant zebrafish IGFBP-5a and -5b
and human IGFBP-5 were produced in HEK 293 cells and
purified from the culture medium. HEK 293 cells were
used because of their high transfection efficiency. Human
and zebrafish IGFBP-5s had apparent sizes of36 kDa on
SDS-PAGE (Fig. 3A), and they were all able to bind IGF-1,
as shown by ligand blot (Fig. 3A).
We next determined the biological activities of ze-
brafish IGFBP-5a and -5b and compared them to that of
human IGFBP-5. As shown in Fig. 3B, addition of IGF-1 to
cultured U2OS cells caused a significant increase in cell
growth. When human IGFBP-5, zebrafish IGFBP-5a, or
zebrafish IGFBP-5b was added together with IGF-1 at a 1:1
M ratio, they abolished the IGF-1-induced increase. Addi-
tion of any one of these IGFBP-5s alone had little effect.
Similar results were also obtained in HEK 293 cells (Fig.
3C). These results suggest that zebrafish igfbp-5a and -5b
encode secreted proteins that bind IGF-1 and modulate
IGF-1 actions.
Both IGFBP-5a and -5b are localized in the nucleus,
but only IGFBP-5b has TA activity
Previous studies have shown that human IGFBP-5 is not
only secreted but can also be found in the nucleus of
UTRs and ORF, respectively. D) Chromosomal loci of IGFBP-5 genes in various vertebrate genomes. Arrows indicate the transcript
orientation. IGFBP-2, IGFBP-5, TNS1, STK11IP, and SLC4A3 are shown as black box, open box, gray box, vertical-line filled box, and
wave-line filled box, respectively. Asterisk indicates partial transcript information from gene annotation. (Chromosomal locus of
SLC4A3 in zebrafish is unknown.) E) Phylogenetic analysis of several teleost IGFBP-5a and -5b. Values on branches are percentages
of replicate trees in which genes clustered together in the bootstrap test (1000 replicates). Branch lengths are drawn in units of 0.05
aa substitutions/site.
Figure 2. Zebrafish igfbp-5a and -5b exhibit distinct
spatial and temporal expression patterns. A) RT-
PCR analysis of igfbp-5a and -5b mRNAs in female
and male adult zebrafish tissues. B) RT-PCR anal-
ysis of igfbp-5a and -5b mRNAs in zebrafish embryos at the indicated stages. Developmental stages are shown at top. hpf,
hours postfertilization. C) In situ hybridization analysis of igfbp-5a mRNA in whole-mount zebrafish embryos. Developmen-
tal stage is at top right in each panel. a, b) Lateral view of yolk tube/sac region with anterior at left. c) Ventral view of gill
arch region with anterior at top. Arrowheads indicate one representative epidermal cell. d–f) Dorsal view of head region
with anterior at top. Dotted line indicates position of otic vesicles. D) In situ hybridization analysis of igfbp-5bmRNA. a, b) Lateral view
of trunk regionwith anterior at left. Arrowhead indicates signals in somites. c, d)Lateral viewof head regionwith anterior at left.Dotted
line indicates positionof otic vesicles. e)Ventral viewof gill arch regionwith anterior at top.Arrows indicate signals in gill arch. f)Dorsal
view of head region with anterior at top. Arrowhead indicates signal in midbrain. Scale bars 	 100 m.
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cultured mammalian cells and mouse embryos (4,
17–19, 21). Furthermore, the IGFBP-5 N domain has
TA activity (19, 21). Because both zebrafish IGFBP-5s
contain a consensus NLS in their C domains (Fig. 1A,
open box), we investigated the possible nuclear local-
ization of zebrafish IGFBP-5a and -5b. U2OS cells were
chosen for subcellular localization analysis because of
their large and flattened cell bodies. When cells were
transfected with human IGFBP-4:EGFP, the EGFP sig-
nal was detected only in the cytoplasm (Fig. 4A). But
when cells were transfected with human IGFBP-5:EGFP,
the EGFP signal was seen in the nucleus. Like human
IGFBP-5:EGFP, zebrafish IGFBP-5a:EGFP, and -5b:
EGFP were also found in the nucleus (Fig. 4A). Similar
results were also observed in HEK 293 cells (data not
shown).
We next investigated whether zebrafish IGFBP-5a and/or
-5b have any TA activity. HEK 293 cells were used because
of the high transfection efficiency (21). The zebrafish
IGFBP-5b N domain caused a GAL4-dependent TA 4-fold
greater than the pBIND control group when tested in
HEK 293 cells (Fig. 4B). In contrast, the zebrafish IG-
FBP-5a N domain did not cause any significant increase.
As reported previously (19, 21), the human IGFBP-5 N
Figure 3. Both zebrafish IGFBP-5a and -5b can
bind IGF-1 and regulate its biological activity.
A) Western immunoblot and ligand blot anal-
yses of purified zebrafish IGFBP-5a and -5b
and human IGFBP-5 proteins. L, ligand blot with DIG-labeled IGF-1; S, silver staining; W, Western immunoblot with an
anti-myc antibody. B, C) Effects of various IGFBP-5s on IGF-1-stimulated cell growth in U2OS cells (B) and HEK 293 cells
(C). Values are means sd of 2 separate experiments, each performed in triplicate. Groups with different letters are
significantly different from each other (P
0.05).
Figure 4. Nuclear localization and TA activities of zebrafish IGFBP-5a and -5b.
A) Subcellular localization of IGFBP:EGFP. U2OS cells were transfected with human
IGFBP-4:EGFP (IGFBP-4), human IGFBP-5:EGFP (IGFBP-5), zebrafish IGFBP-5a:
EGFP (IGFBP-5a), and zebrafish IGFBP-5b:EGFP (IGFBP-5b) expression plasmid.
EGFP signal was visualized (left panels) 24 h after transfection. Corresponding DAPI
staining is shown in the middle panels and merged views in the right panels. Scale
bar	 25 m. B, C) N domain of zebrafish IGFBP-5b but not that of IGFBP-5a has TA
activity in HEK 293 cells (B) and ZF4 cells (C). TA activity is expressed as fold over
the pBIND control group. Values are means  sd (n	3–5). Groups with different
letters are significantly different from each other (P
0.05). D) Expression levels of
fusion proteins were analyzed by Western immunoblot using an anti-GAL4 (DBD)
antibody and an anti-tubulin antibody.
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domain caused a 20-fold increase in activating the re-
porter gene expression. To rule out the possibility of
species-specific effect, the TA activities of these fusion
proteins were also tested in ZF4 cells, a cell line derived
from zebrafish embryos. In these zebrafish cells, human
IGFBP-5 still had the strongest activity (9-fold increase
over the pBIND control, P
0.001) and the zebrafish
IGFBP-5b N domain had significant activity (3-fold in-
crease, P
0.05). Again, the zebrafish IGFBP-5a N domain
had no activity (Fig. 4C). Western immunoblot analysis
revealed that expression levels of these fusion proteins
were similar (Fig. 4D), thus excluding the possibility that
the difference was due to different levels of protein
expression and/or degradation.
Several unique residues in the IGFBP-5 N domain are
critical for the TA activity
The 2 zebrafish IGFBP-5s share the same domain
arrangement, high sequence identity, nuclear localiza-
tion, and the ability to bind IGFs, but only IGFBP-5b
has TA activity. Taking advantage of this finding, we
compared the amino acid sequences of these 2 highly
homologous proteins with that of human IGFBP-5.
Among the 8 residues in the human IGFBP-5 N domain
that are known to be critical for its TA ability (21), 5 are
conserved in zebrafish IGFBP-5a and -5b (Fig. 5A,
asterisk). When 3 of these conserved residues in ze-
brafish IGFBP-5b were substituted with their corre-
sponding residues from human IGFBP-1 (E8A/D11S/
E43L), the TA activity was abolished (Fig. 5B). Because
zebrafish IGFBP-5b, but not IGFBP-5a, has TA activity,
we focused on the 12 residues that differed between
these 2 zebrafish IGFBP-5s in this region (Fig. 5A,
caret). Among the 4 tested, we found that changing P22
or H56 in IGFBP-5b to the corresponding residue in
IGFBP-5a reduced the TA activity by 50%, and the
P22R/H56R double mutant had essentially no TA
activity (Fig. 5B). In comparison, the L15M and N64I
Figure 5. Two unique amino acid changes in the IGFBP-5a N domain
are responsible for its lack of TA activity. A) Sequence alignment of
the N domain of human IGFBP-5 and zebrafish IGFBP-5a and -5b.
Asterisks indicate residues known to be important for the TA activity
of human IGFBP-5; carets indicate residues that differ between
zebrafish IGFBP-5a and -5b; open squares indicate residues tested in
this study. B–D) TA activities of wild-type and mutant zebrafish
IGFBP-5b and -5a. Indicated constructs were introduced into HEK
293 cells together with a GAL4 reporter plasmid by transient transfection. Values are expressed as percentages of the
wild-type zebrafish IGFBP-5b N-domain group (B, C) or the human IGFBP-5 N-domain group (D). Values are means  sd
(n	3). Groups with the same letters are not significantly different from each other (P
0.05). E) Expression levels of mutant
fusion proteins were analyzed by Western immunoblot using an anti-GAL4 (DBD) antibody and an anti-tubulin antibody.
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mutants had only moderate effects. These results sug-
gest that R22 and R56 in the IGFBP-5a N domain are
largely responsible for its lack of TA activity. To further
test whether these 2 positions are sufficient to establish
the TA activity, we changed R22 and R56 in the zebrafish
IGFBP-5a N domain to the corresponding residues of
IGFBP-5b in individual and double mutants. The R22P
mutant had significant TA activity. The R22P/R56H dou-
blemutant had TA activity comparable to that of zebrafish
IGFBP-5b (Fig. 5C). Taken together, our results suggest
that the 2 different amino acids in positions 22 and 56 are
responsible for the different TA activity observed in the 2
zebrafish IGFBP-5s.
We also investigated the structural determinants ac-
counting for the different activities observed between
human IGFBP-5 and zebrafish IGFBP-5b. Among the 8
residues in the human IGFBP-5 N domain that are
known to be critical for its TA ability (21), 3 of them
differ between zebrafish IGFBP-5b and human IGFBP-5
(Fig. 5A, asterisk). Changing the zebrafish IGFBP-5 resi-
due at position 56 into the corresponding residue from
the human sequence resulted in a significant increase in
its activity (R56Q and R22P/R56Qmutants in Fig. 5C and
H56Q mutant in Fig. 5D). We further generated double
and triple zebrafish IGFBP-5b mutants, H56Q/G52E and
H56Q/G52E/Q12E, by changing residues from the ze-
brafish IGFBP-5b into the corresponding ones from the
human IGFBP-5 sequence. The H56Q/G52E mutant had
80% activity compared to the human IGFBP-5 (Fig. 5D),
and the H56Q/G52E/Q12E mutant fully achieved the
same high TA activity as human IGFBP-5. All mutants
were expressed at comparable levels as shown by immu-
noblot (Fig. 5E). These results indicate that the difference
in TA activities observed between human IGFBP-5 and
zebrafish IGFBP-5b is due to their different amino acid
residues in positions 12, 52, and 56.
DISCUSSION
In this study we identified 2 igfbp-5 genes in zebrafish.
Several lines of evidence indicated that they are co-
orthologs of human IGFBP-5: 1) sequence comparison
at the protein level showed that they share the highest
identity with human IGFBP-5, 2) phylogenetic analysis
grouped the 2 zebrafish IGFBPs in the IGFBP-5 cluster,
3) the gene structure and exon/intron size are most
similar to human IGFBP-5, and 4) the chromosome loci
indicated conserved synteny with human IGFBP-5. We
also found 2 igfbp-5 genes in other teleost fish. Both the
conserved synteny and phylogenetic analyses indicate
that the duplication event that produced these 2 genes
happened early in teleost evolution (Fig. 6).
In humans and mice, IGFBP-5 mRNA has been de-
tected in a wide range of tissues and cell types. Analyzing
the expression patterns in zebrafish, we found that the 2
duplicate igfbp-5 genes diverge in expression pattern both
spatially and temporally. In adult tissues, although igfbp-5b
is expressed in all the tissues examined at relatively high
levels, igfbp-5a is most strongly expressed in brain and gill.
During embryogenesis, igfbp-5b is expressed earlier than
igfbp-5a. More interestingly, they are expressed in dis-
tinct tissues and cells. Although igfbp-5a expression is
restricted in the epidermal cells and in the inner ear,
igfbp-5b is expressed in somites, branchial arches, pec-
toral fin, and several domains in the brain. The diver-
gent temporal and spatial expression patterns indicate
that the cis-regulatory elements in these 2 genes may
have diverged after the duplication event. Studies of
duplicated genes in zebrafish indicated that this may be
a common mechanism for diversification (36, 37).
Further studies are needed to determine the conserved
and divergent cis-regulatory elements in these 2 ze-
brafish igfbp-5 genes.
Mammalian IGFBP-5 is a multifunctional protein
that contains several structural modules/domains. We
performed molecular, biochemical and cell biological
approaches to identify structural components that have
diversified in the duplicate zebrafish IGFBP-5s. We
found that although some of the domains are preserved
in both genes (LBD and NLS), others (TA) diverged
during evolution (Fig. 6). Protein function usually
requires intra- and intermolecular domain interactions.
Therefore, the related domains usually coevolve (38). It
has been shown that TA activity and nuclear localiza-
tion are well correlated in the 6 IGFBPs, with IGFBP-3
and -5 showing nuclear localization and possessing the
highest TA activity (21). It is intriguing to ask why
IGFBP-5a preserves the NLS while losing the TA do-
main. One possible explanation from the structural
point of view is that the conserved stretch of basic
residues in the C domain has multiple functional
roles. In addition to being a functional NLS (4, 19),
this region is also involved in IGFBP-5 interaction
with ALS, heparin, and ECM components (39, 40).
Therefore, selection force may conserve these resi-
dues even if one of their functions become unneces-
Figure 6. Proposed model for the gene expression and
functional divergence of igfbp-5 genes in teleost fish. The
ancestral IGFBP-5 gene was duplicated early in teleost evolu-
tion as the result of a genome duplication event. The dupli-
cated igfbp-5 genes may have undergone subfunctionalization
at the levels of expression pattern, through divergent expres-
sion regulation (indicated by different arrows), and protein
functionality, through the loss of critical structural motifs,
such as the TA domain in the case of zebrafish igfbp-5a.
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sary. The LBD motif and the TA domain have been
shown to be structurally separable and functionally
independent (19). It is possible that IGFBP-5a may
have lost the TA activity while retaining its IGF-
binding function.
The 2 zebrafish IGFBP-5s share the same domain
arrangement, high sequence identity, and the ability to
bind IGFs, but only zebrafish IGFBP-5b has TA activity.
Taking advantage of this finding, we were able to
identify the key residues critical for the TA activity. By
swapping their different residues, we discovered that 2
residues at positions 22 and 56 are both necessary and
sufficient for the TA activity in zebrafish IGFBP-5s.
These results indicate that IGFBP-5a lacks TA activity
because of its unique residues in these critical positions.
This conclusion is also consistent with our current
understanding of gene evolution. After gene duplica-
tion, it is thought that the duplicated genes are likely to
be retained if they acquire nonredundant functions
(41). The high divergence of the TA domains observed
in the duplicated zebrafish igfbp-5 paralogs may account
for an adaptation or specialization of function of these
2 genes. We speculate that this may not be unique to
zebrafish, as aligning the IGFBP-5 N domain sequences
of zebrafish, fugu, and stickleback together with that of
human and mouse suggests that position 56 showed
clear divergence in the 2 branches. Specifically, it is an
R in all members of the IGFBP-5a group, whereas Q or
H in the IGFBP-5b group (Supplemental Fig. 1). The
other position, 22, identified in this study does not
seem to be conserved in the 2 groups, suggesting that
this residue change is a more recent event during
evolution in zebrafish. When we tested the TA activity
in ancestral IGFBPs in amphioxus (unpublished re-
sults), we found that they do exhibit high TA activity
like the human IGFBP-5, suggesting that this activity
has an ancient origin.
It has been shown that zebrafish contain 2 igf-1 genes,
2 igf-2 genes, and 2 igf-1r genes (26, 42). In addition,
zebrafish have 2 igfbp-1 genes, 2 igfbp-2 genes, and 2
igfbp-6 genes (27–29). In this study, we provide evidence
that there are 2 functional igfbp-5 genes in zebrafish and
other teleost fish, igfbp-5a and igfbp-5b.We show that the
duplicated igfbp-5s exhibited nonoverlapping expres-
sion patterns during zebrafish embryogenesis. We also
determined the structural changes accounting for func-
tional divergence by mapping critical amino acid
changes in the TA domain. These findings provide
insight into the evolution of the IGFBP gene family and
lay the foundations for further elucidation of the
physiological functions of the nuclear IGFBP-5 and its
TA activity in vivo.
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